Follow
Inferior quality drugs are not only harmful to health but waste of money for both government and private consumers. A poor quality medicine may contain toxic substances that have been added unintentionally. Medicines that contain little or none of the claimed ingredient will not have the intended therapeutic effect.
In pharmaceuticals, less is more. Making inferior products does not save money. GMP is designed to ensure that mistakes are not made. GMP implementation is an investment in good quality medicine. This will improve the health of individual patients and communities, as well as benefit the pharmaceutical industry and health professionals.
Additionally, most countries will accept the import and sale of drugs manufactured to internationally recognized GMP. Governments that want to promote their country’s pharmaceutical exports can do so by mandating GMP for all drug manufacturing and training their inspectors on GMP requirements.
Good Manufacturing Practice (GMP) is a system for ensuring that products are produced and controlled according to consistent quality standards. It is designed to minimize risks associated with any pharmaceutical manufacturing that cannot be eliminated through final product testing. The main risks are: unexpected contamination of products, causing health damage or even death; mislabeling of containers, which means patients may receive the wrong medication; Insufficient or excessive active ingredients, resulting in ineffective treatment or adverse effects. GMP covers all aspects of manufacturing; From basic materials, premises and equipment to staff training and personal hygiene. Detailed, written procedures are essential for every process that can affect the quality of the finished product. Systems must be in place to provide documented evidence that correct procedures are followed consistently at each step of the manufacturing process – every time a product is made. WHO has established detailed guidelines for good manufacturing practices. Many countries have developed their own requirements for GMP based on WHO GMP. Others have harmonized their requirements, for example in Southeast Asian Nations (ASEAN), the European Union and through the Pharmaceutical Inspection Convention.
